In CRC, previous studies have reported 35-37 that elevated E2F1 expression exhibits an inverse association with cell proliferation and a positive correlation with increased apoptotic levels, suggesting a tumor-suppressive role in CRC progression. This evidence concerns the gene E2F1 and neoplasm.